CYPH
NASDAQCypherpunk Technologies Inc.
Cypherpunk Technologies Inc. (CYPH) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 1 wire item for CYPH, including 1 earnings update. The most recent was published Nov 10, 2026.
CYPH rankings
Financial highlights
Full financials- Net income, TTM
- -$877.0K
- Cash
- $7.62M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks33-86%
2026-05-172026-11-08
Mix1690d
- Insider10(63%)
- SEC Filings3(19%)
- Other1(6%)
- Leadership1(6%)
- Earnings1(6%)
Activity · 52 weeks8936 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- PRCypherpunk Technologies to Report Third Quarter 2026 Financial Results on November 16, 2026CAMBRIDGE, Mass., Nov. 10, 2026 /CNW/ -- Cypherpunk Technologies Inc. (NASDAQ:CYPH) ("Cypherpunk"), a privacy technology company, today announced it will report third quarter 2026 financial results on Monday, November 16, 2026. The Company will discuss the results in a live audio event hosted on X via X Spaces at 9:00 a.m. ET. The discussion will be publicly accessible in real time to all listeners at https://x.com/cypherpunk, where the live event will appear at the scheduled time. A replay will be available on the Company's X profile and on the investor relations section of the Company's website at cypherpunk.com following the event. About CypherpunkCypherpunk Technologies is a privacy tech
- INSIDERSEC Form 4 filed by Cypherpunk Technologies Inc.4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Cypherpunk Technologies Inc.4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 3 filed by new insider Fabiano Amanda3 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERDirector Martin Patricia A. sold $193,000 worth of shares (50,000 units at $3.86), decreasing direct ownership by 30% to 118,750 units (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERDirector Oei Khing Djien sold $661,500 worth of shares (168,750 units at $3.92), closing all direct ownership in the company (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Appoints Amanda Fabiano to Board of DirectorsVeteran mining executive brings operational depth from Nakamoto, TeraWulf, Galaxy, and Fidelity as Cypherpunk launches 4.2 GSol/s Zcash mining fleetCypherpunk Mining generated 3,023.13 ZEC in first weeks of operation; Added to TreasuryCAMBRIDGE, Mass., Sept. 22, 2026 /CNW/ -- Cypherpunk Technologies Inc. (NASDAQ:CYPH) ("Cypherpunk"), a privacy technology company, today announced the appointment of Amanda Fabiano to its Board of Directors.One of the most experienced operators in digital asset mining and infrastructure, Fabiano currently serves as Chief Operating Officer of Nakamoto Inc., a publicly listed bitcoin-focused company, and as an independent director of TeraWulf Inc., a public bitco
- SECSEC Form 8-K filed by Cypherpunk Technologies Inc.8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- INSIDERDirector Dietz Thomas John sold $34,400 worth of shares (20,000 units at $1.72), decreasing direct ownership by 13% to 132,500 units (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Head of Mining Zhang Kevin to satisfy withholding obligation4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERNew insider Zhang Kevin claimed ownership of 330,904 shares (SEC Form 3)3 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERChief Investment Officer Mcevoy William Patrick Iii exercised 16,570,852 in-the-money shares at a strike of $0.00 (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERLarge owner Winklevoss Capital Fund, Llc exercised 16,570,852 in-the-money shares at a strike of $0.00 (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Launches World's Largest Zcash Mining FleetEquity-based transaction with Winklevoss Capital activates 4.2 GSol/s of live, U.S.-based hashrate; approximately 18% of the Zcash network; Industry veteran Kevin Zhang joins as Head of MiningCAMBRIDGE, Mass., Aug. 18, 2026 /CNW/ -- Cypherpunk Technologies Inc. (NASDAQ:CYPH) ("Cypherpunk") today announced the launch of Cypherpunk Mining, which is now the largest Zcash mining fleet in the world, through a $33.33 million equity-based transaction with Winklevoss Capital. The fleet is online today, with approximately 4.2 GSol/s of Equihash hashrate deployed across the United States, which currently represents approximately 18% of the total Zcash network."Up until now, investors have had limited
- SECSEC Form 10-Q filed by Cypherpunk Technologies Inc.10-Q - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Reports Second Quarter 2026 Financial ResultsCAMBRIDGE, Mass., Aug. 12, 2026 /CNW/ -- Cypherpunk Technologies Inc., (NASDAQ:CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026."In the second quarter, Cypherpunk built upon the momentum established earlier this year through the disciplined execution of our Zcash digital asset treasury strategy, increasing our treasury holdings to 323,394.38 ZEC, and welcoming Dev Ojha, founder of Valar Group, as an Advisor," said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. "Our Leap Therapeutics subsidiary reached alignment with the FDA on a proposed Phase 3 trial in a DKK1-high, second-line, metastatic colorectal cancer population, with ob
- PRLeap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer ResearchPeer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapyCAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (NASDAQ:CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.The publication, "Sirexatamab in Combination with Bevacizumab and Chemo
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- INSIDERSEC Form 4 filed by Director Richard Christian M (for withholding tax)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Oei Khing Djien (withholding obligation)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Dietz Thomas John (tax withholding)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Martin Patricia A. to cover taxes4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
CYPH FAQ
8 questionsWhat is the latest news on CYPH?
In the last 30 days Quantisnow tracked 1 wire item for CYPH: 1 earnings update. The most recent was published on November 10, 2026.Is CYPH profitable?
No. Cypherpunk Technologies Inc. reported a net loss of $877.0K for the twelve months ended Jun 30, 2026.How much cash and debt does CYPH have?
Cypherpunk Technologies Inc. reported $7.62M in cash and cash equivalents on its most recent balance sheet in SEC filings.Where does CYPH stock trade?
Cypherpunk Technologies Inc. (CYPH) is listed on NASDAQ.What sector and industry is CYPH in?
Cypherpunk Technologies Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about CYPH?
Cypherpunk Technologies Inc. has had 1 recent analyst action on file. The most recent action was from Cantor Fitzgerald: Overweight with a $0.90 price target on 2026-07-01. Recent price targets cluster around $0.90.What companies are similar to CYPH?
Notable peers in the same industry include MRK (Merck & Company Inc.), NVO (Novo Nordisk A/S), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories). Compare CYPH side-by-side with any of them on Quantisnow.How can I track CYPH on Quantisnow?
Quantisnow aggregates Cypherpunk Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CYPH to receive live email and push alerts on every new disclosure.